Fabrice Piu - Otonomy VP Devel

OTICDelisted Stock  USD 0.11  0.00  0.00%   

Insider

Fabrice Piu is VP Devel of Otonomy
Phone619 323 2200
Webhttps://www.otonomy.com

Otonomy Management Efficiency

The company has return on total asset (ROA) of (0.3812) % which means that it has lost $0.3812 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1886) %, meaning that it created substantial loss on money invested by shareholders. Otonomy's management efficiency ratios could be used to measure how well Otonomy manages its routine affairs as well as how well it operates its assets and liabilities.
Otonomy currently holds 16 M in liabilities with Debt to Equity (D/E) ratio of 1.43, which is about average as compared to similar companies. Otonomy has a current ratio of 1.71, which is within standard range for the sector. Debt can assist Otonomy until it has trouble settling it off, either with new capital or with free cash flow. So, Otonomy's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Otonomy sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Otonomy to invest in growth at high rates of return. When we think about Otonomy's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Michael GarciaAlgoma Steel Group
59
Marc SummeyGameStop Corp
N/A
Ken SloanOlympic Steel
N/A
Ken SuzukiGameStop Corp
N/A
Qunli XingMaanshan Iron Steel
N/A
Timothy HarrisAllegheny Technologies Incorpor
49
Josh KruegerGameStop Corp
N/A
Maohan ZhangMaanshan Iron Steel
54
Zhanhong MaoMaanshan Iron Steel
53
Reginald AimeGameStop Corp
59
Loris MolinoAlgoma Steel Group
N/A
Kurtis WolfGameStop Corp
N/A
Feng ZhouNetEase
46
Angela VenukGameStop Corp
N/A
Tom PetersenGameStop Corp
N/A
Neda PacificoGameStop Corp
N/A
William SimonGameStop Corp
60
John MooneyOlympic Steel
N/A
Lisa ChristenOlympic Steel
47
Margaret ShiNetEase
N/A
Kelli DurkinGameStop Corp
N/A
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. Otonomy, Inc. was incorporated in 2008 and is headquartered in San Diego, California. Otonomy operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 51 people. Otonomy [OTIC] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Otonomy Leadership Team

Elected by the shareholders, the Otonomy's board of directors comprises two types of representatives: Otonomy inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Otonomy. The board's role is to monitor Otonomy's management team and ensure that shareholders' interests are well served. Otonomy's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Otonomy's outside directors are responsible for providing unbiased perspectives on the board's policies.
David Skarinsky, VP Clinical
Breianna Bowen, VP HR
Paul Cayer, CFO, Chief Bus. Officer and Secretary
Alan Foster, Chief Officer
James CPA, VP Controller
David Weber, CEO and President and Director
Rick MD, CoFounder Panel
Barbara Finn, VP Assurance
Allen Ryan, CoFounder Panel
Fabrice Piu, VP Devel

Otonomy Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Otonomy a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Consideration for investing in Otonomy Pink Sheet

If you are still planning to invest in Otonomy check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Otonomy's history and understand the potential risks before investing.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency